Cardiac Biomarkers are Associated with Incident Fracture Risk in Advanced Chronic Kidney Disease

Louise Aaltonen1, Tapio Hellman2, Roosa Lankinen2

  • 1Kidney Center, Department of Medicine, Turku University Hospital, PL 52, Kiinamyllynkatu 4-8, 20521, Turku, Finland. louise.aaltonen@varha.fi.

PubMed

Insights

Cardiovascular health markers and a composite risk score predict fracture risk in advanced chronic kidney disease (CKD) patients. This highlights the link between heart health and bone fragility in this high-risk population.

Area of Science:

  • Nephrology
  • Cardiology
  • Bone Metabolism

Background:

  • Cardiovascular disease (CVD) is linked to higher fracture risk in the general population.
  • Limited data exist on cardiovascular health and incident fracture risk in advanced chronic kidney disease (CKD) patients, a population highly susceptible to fractures.

Purpose of the Study:

  • To investigate the association between cardiovascular health and incident fracture risk in patients with advanced CKD (stages G4-5).
  • To evaluate the predictive value of cardiovascular biomarkers and a composite risk score for fractures in this cohort.

Main Methods:

  • Prospective cohort study of 210 patients with CKD stage G4-5.
  • Baseline assessments included laboratory parameters (Troponin T - TnT, Pro-brain Natriuretic Peptide - ProBNP), abdominal aortic calcification, echocardiography, flow-mediated dilation, intima-media thickness, and maximal stress ergometry.
  • Incident fractures were recorded over a 5-year follow-up period. Multivariable Cox proportional hazards models were used for analysis.

Main Results:

  • A total of 51 fractures occurred in 40 patients (19%) over 5 years.
  • Elevated TnT and ProBNP levels were independently associated with increased fracture risk, even after adjusting for coronary artery disease (CAD).
  • Patients unable to complete ergometry had a significantly higher fracture risk. A composite cardiovascular risk score integrating TnT, ProBNP, and ergometry data strongly predicted incident fractures (HR 1.373).

Conclusions:

  • Cardiovascular health, assessed through biomarkers like TnT and ProBNP, and functional capacity (ergometry), is significantly associated with incident fracture risk in advanced CKD.
  • A composite cardiovascular risk score effectively identifies patients with advanced CKD at higher risk for fractures.
  • These findings underscore the importance of evaluating cardiovascular health in managing fracture risk in CKD patients.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
119
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
69
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
63
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
405